Table 1 Cases and controls are matched by age, race, and history of hypertension
From: Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
Total | Controls | Cases | ||
|---|---|---|---|---|
Number of patients | 140 | 111 | 29 | |
Age (years) | Median (range) | 56 (32–85) | ||
<50 yo | 39 (28%) | 30 (27%) | 9 (31%) | |
>50 yo | 101 (72%) | 81 (73%) | 20 (69%) | |
Gender | Female | 140 (100%) | ||
Race | White | 112 (80%) | 93 (84%) | 23 (79%) |
Asian | 18 (13%) | 12 (11%) | 2 (7%) | |
Black | 10 (7%) | 6 (5%) | 4 (14%) | |
Baseline LVEF | Median (range) | 65% (50-77%) | ||
History of Hypertenson | Yes | 23 (16.4%) | 18 (16%) | 5 (17%) |
No | 117 (84%) | 93 (84%) | 24 (83%) |